Global Regenerative Medicines Market 2022-2026

再生医療の世界市場2022-2026:細胞・組織ベース、遺伝子治療

◆タイトル:Global Regenerative Medicines Market 2022-2026
◆商品コード:IRTNTR41171-22
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2022年5月4日
◆ページ数:約120
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、その他地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥332,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥399,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥532,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

テクナビオ社は、世界の再生医療市場規模が2022年~2026年まで年平均14.57%成長し、286.7億ドルに達すると予測しています。本調査レポートは、再生医療の世界市場について調査し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、技術別(細胞・組織ベース、遺伝子治療)分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析などを掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の再生医療市場規模:技術別(細胞・組織ベース、遺伝子治療)
・顧客状況
・地域別状況
・推進要因・課題・動向
・企業状況
・企業分析

Global Regenerative Medicines Market 2022-2026
Technavio has been monitoring the regenerative medicines market and it is poised to grow by $ 28.67 bn during 2022-2026, accelerating at a CAGR of 14.57% during the forecast period. Our report on the regenerative medicines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic diseases, increasing support from the public and private healthcare organizations, and increasing the adoption of stem cell therapy.
The regenerative medicines market analysis includes the technology segment and geographic landscape.

Technavio’s regenerative medicines market is segmented as below:

By Technology
• Cell and tissue-based
• Gene therapy

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing number of clinical trials as one of the prime reasons driving the regenerative medicines market growth during the next few years. Also, emerging technological advances and strategic partnerships and acquisitions will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the regenerative medicines market covers the following areas:
• Regenerative medicines market sizing
• Regenerative medicines market forecast
• Regenerative medicines market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading regenerative medicines market vendors that include AbbVie Inc., Amgen Inc., Baxter International Inc., Becton Dickinson, and Co., Cook Group Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Integra Lifesciences Corp., Johnson and Johnson, Medtronic Plc, Merck and Co. Inc., Mesoblast Ltd., MiMedx Group Inc., Novartis AG, Nuvasive Inc., Organogenesis Inc., Smith and Nephew plc, Thermo Fisher Scientific Inc., Vericel Corp., and Zimmer Biomet Holdings Inc. Also, the regenerative medicines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/regenerative-medicine-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

【資料の目次】

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Technology
o 5.1 Market segments
o Exhibit 24: Chart on Technology – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Technology – Market share 2021-2026 (%)
o 5.2 Comparison by Technology
o Exhibit 26: Chart on Comparison by Technology
o Exhibit 27: Data Table on Comparison by Technology
o 5.3 Cell and tissue-based – Market size and forecast 2021-2026
o Exhibit 28: Chart on Cell and tissue-based – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Cell and tissue-based – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Cell and tissue-based – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Cell and tissue-based – Year-over-year growth 2021-2026 (%)
o 5.4 Gene therapy – Market size and forecast 2021-2026
o Exhibit 32: Chart on Gene therapy – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Gene therapy – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Gene therapy – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Gene therapy – Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Technology
o Exhibit 36: Market opportunity by Technology ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 42: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 58: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 Germany – Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.9 Japan – Market size and forecast 2021-2026
o Exhibit 66: Chart on Japan – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Japan – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Japan – Year-over-year growth 2021-2026 (%)
o 7.10 UK – Market size and forecast 2021-2026
o Exhibit 70: Chart on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK – Year-over-year growth 2021-2026 (%)
o 7.11 China – Market size and forecast 2021-2026
o Exhibit 74: Chart on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 85: AbbVie Inc. – Overview
o Exhibit 86: AbbVie Inc. – Product / Service
o Exhibit 87: AbbVie Inc. – Key offerings
o 10.4 Baxter International Inc.
o Exhibit 88: Baxter International Inc. – Overview
o Exhibit 89: Baxter International Inc. – Business segments
o Exhibit 90: Baxter International Inc. – Key news
o Exhibit 91: Baxter International Inc. – Key offerings
o Exhibit 92: Baxter International Inc. – Segment focus
o 10.5 Becton Dickinson and Co.
o Exhibit 93: Becton Dickinson and Co. – Overview
o Exhibit 94: Becton Dickinson and Co. – Business segments
o Exhibit 95: Becton Dickinson and Co. – Key news
o Exhibit 96: Becton Dickinson and Co. – Key offerings
o Exhibit 97: Becton Dickinson and Co. – Segment focus
o 10.6 Cook Group Inc.
o Exhibit 98: Cook Group Inc. – Overview
o Exhibit 99: Cook Group Inc. – Product / Service
o Exhibit 100: Cook Group Inc. – Key offerings
o 10.7 Integra LifeSciences Corp.
o Exhibit 101: Integra LifeSciences Corp. – Overview
o Exhibit 102: Integra LifeSciences Corp. – Business segments
o Exhibit 103: Integra LifeSciences Corp. – Key news
o Exhibit 104: Integra LifeSciences Corp. – Key offerings
o Exhibit 105: Integra LifeSciences Corp. – Segment focus
o 10.8 Medtronic Plc
o Exhibit 106: Medtronic Plc – Overview
o Exhibit 107: Medtronic Plc – Business segments
o Exhibit 108: Medtronic Plc – Key news
o Exhibit 109: Medtronic Plc – Key offerings
o Exhibit 110: Medtronic Plc – Segment focus
o 10.9 Merck and Co. Inc.
o Exhibit 111: Merck and Co. Inc. – Overview
o Exhibit 112: Merck and Co. Inc. – Business segments
o Exhibit 113: Merck and Co. Inc. – Key news
o Exhibit 114: Merck and Co. Inc. – Key offerings
o Exhibit 115: Merck and Co. Inc. – Segment focus
o 10.10 Organogenesis Inc.
o Exhibit 116: Organogenesis Inc. – Overview
o Exhibit 117: Organogenesis Inc. – Product / Service
o Exhibit 118: Organogenesis Inc. – Key offerings
o 10.11 Smith and Nephew plc
o Exhibit 119: Smith and Nephew plc – Overview
o Exhibit 120: Smith and Nephew plc – Business segments
o Exhibit 121: Smith and Nephew plc – Key news
o Exhibit 122: Smith and Nephew plc – Key offerings
o Exhibit 123: Smith and Nephew plc – Segment focus
o 10.12 Thermo Fisher Scientific Inc.
o Exhibit 124: Thermo Fisher Scientific Inc. – Overview
o Exhibit 125: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 126: Thermo Fisher Scientific Inc. – Key news
o Exhibit 127: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 128: Thermo Fisher Scientific Inc. – Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 129: Inclusions checklist
o Exhibit 130: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 131: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 132: Research methodology
o Exhibit 133: Validation techniques employed for market sizing
o Exhibit 134: Information sources
o 11.5 List of abbreviations
o Exhibit 135: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Technology
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on Technology – Market share 2021-2026 (%)
Exhibits25: Data Table on Technology – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Technology
Exhibits27: Data Table on Comparison by Technology
Exhibits28: Chart on Cell and tissue-based – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Cell and tissue-based – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Cell and tissue-based – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Cell and tissue-based – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Gene therapy – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Gene therapy – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Gene therapy – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Gene therapy – Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Technology ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Japan – Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Japan – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Japan – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK – Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: AbbVie Inc. – Overview
Exhibits86: AbbVie Inc. – Product / Service
Exhibits87: AbbVie Inc. – Key offerings
Exhibits88: Baxter International Inc. – Overview
Exhibits89: Baxter International Inc. – Business segments
Exhibits90: Baxter International Inc. – Key news
Exhibits91: Baxter International Inc. – Key offerings
Exhibits92: Baxter International Inc. – Segment focus
Exhibits93: Becton Dickinson and Co. – Overview
Exhibits94: Becton Dickinson and Co. – Business segments
Exhibits95: Becton Dickinson and Co. – Key news
Exhibits96: Becton Dickinson and Co. – Key offerings
Exhibits97: Becton Dickinson and Co. – Segment focus
Exhibits98: Cook Group Inc. – Overview
Exhibits99: Cook Group Inc. – Product / Service
Exhibits100: Cook Group Inc. – Key offerings
Exhibits101: Integra LifeSciences Corp. – Overview
Exhibits102: Integra LifeSciences Corp. – Business segments
Exhibits103: Integra LifeSciences Corp. – Key news
Exhibits104: Integra LifeSciences Corp. – Key offerings
Exhibits105: Integra LifeSciences Corp. – Segment focus
Exhibits106: Medtronic Plc – Overview
Exhibits107: Medtronic Plc – Business segments
Exhibits108: Medtronic Plc – Key news
Exhibits109: Medtronic Plc – Key offerings
Exhibits110: Medtronic Plc – Segment focus
Exhibits111: Merck and Co. Inc. – Overview
Exhibits112: Merck and Co. Inc. – Business segments
Exhibits113: Merck and Co. Inc. – Key news
Exhibits114: Merck and Co. Inc. – Key offerings
Exhibits115: Merck and Co. Inc. – Segment focus
Exhibits116: Organogenesis Inc. – Overview
Exhibits117: Organogenesis Inc. – Product / Service
Exhibits118: Organogenesis Inc. – Key offerings
Exhibits119: Smith and Nephew plc – Overview
Exhibits120: Smith and Nephew plc – Business segments
Exhibits121: Smith and Nephew plc – Key news
Exhibits122: Smith and Nephew plc – Key offerings
Exhibits123: Smith and Nephew plc – Segment focus
Exhibits124: Thermo Fisher Scientific Inc. – Overview
Exhibits125: Thermo Fisher Scientific Inc. – Business segments
Exhibits126: Thermo Fisher Scientific Inc. – Key news
Exhibits127: Thermo Fisher Scientific Inc. – Key offerings
Exhibits128: Thermo Fisher Scientific Inc. – Segment focus
Exhibits129: Inclusions checklist
Exhibits130: Exclusions checklist
Exhibits131: Currency conversion rates for US$
Exhibits132: Research methodology
Exhibits133: Validation techniques employed for market sizing
Exhibits134: Information sources
Exhibits135: List of abbreviations



【掲載企業】

AbbVie Inc., Amgen Inc., Baxter International Inc., Becton Dickinson and Co., Cook Group Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Integra LifeSciences Corp., Johnson and Johnson, Medtronic Plc, Merck and Co. Inc., Mesoblast Ltd., MiMedx Group Inc., Novartis AG, Nuvasive Inc., Organogenesis Inc., Smith and Nephew plc, Thermo Fisher Scientific Inc., Vericel Corp., Zimmer Biomet Holdings Inc.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[再生医療の世界市場2022-2026:細胞・組織ベース、遺伝子治療]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆